Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Transonic Systems Inc..
Recruitment status was Recruiting
Information provided by (Responsible Party):
Transonic Systems Inc.
First received: May 29, 2012
Last updated: June 6, 2012
Last verified: June 2012
Cardiac output (CO) is an important hemodynamic variable in the management of critically ill patients. The pulmonary artery catheter (PAC) requires invasive techniques with potential complications and there is increasing interest in less invasive methods of measuring CO. This study is designed to compare CO values from PAC thermodilution (COTD) and ultrasound dilution (COUD).
Post Surgery Patients
||Time Perspective: Prospective
||Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique
Primary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||October 2012 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Age ≥ 18 years of age Presence of arterial catheter plus central venous pressure monitor and pulmonary artery catheter for hemodynamic monitoring.
- Age ≥ 18 years of age
- Presence of arterial catheter plus central venous pressure monitor and pulmonary artery catheter for hemodynamic monitoring.
- Age < 18 years of age
- Patients with structurally abnormal heart (e.g. shunt) (confirmed by history taking)
- Patients who have heparin allergy. (Confirmed by history taking)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01616017
|The Queen's Medical Center
|Honolulu, Hawaii, United States, 96813 |
|Contact: Mihae Yu, MD 808-586-2920 firstname.lastname@example.org |
Transonic Systems Inc.
No publications provided
||Transonic Systems Inc.
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 29, 2012
||June 6, 2012
||United States: Institutional Review Board
United States: Federal Government
Keywords provided by Transonic Systems Inc.:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 20, 2014